Source: Market Exclusive

Paratek: PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to a Vote of Security Holders

PARATEK PHARMACEUTICALS, INC. (NASDAQ:PRTK) Files An 8-K Submission of Matters to a Vote of Security Holders

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Evan Loh's photo - CEO of Paratek

CEO

Evan Loh

CEO Approval Rating

90/100

Paratek is a biopharmaceutical company that develops antibiotic drugs to treat bacterial pneumonia in adults. Read more